相关实验视频
Updated: Jul 1, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
米托富素-2 通过 Wnt/β-catenin 信号增强子宫癌的进展
1Department of Orthopaedic Surgery, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul 03080; Department of Translational Medicine, Seoul National University College of Medicine, Seoul 03080; Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University, Seoul 03080, Korea.
米托素-2 (MFN2) 过度表达与子宫癌预后不佳相关. 减少SiHa细胞中的MFN2通过抑制Wnt/β-catenin介导的EMT来抑制扩散,迁移和瘤生长,这表明MFN2是治疗标.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 米托素-2 (MFN2),一个关键的线粒体融合蛋白,与宫癌的不良结果有关.
- 了解MFN2的作用对于开发向性宫癌治疗非常重要.
研究的目的:
- 调查MFN2在宫癌进展中的作用.
- 评估MFN2在宫癌患者的预后意义.
主要方法:
- 产生了MFN2倒置的SiHa细胞以评估增殖 (细胞计数套件-8),殖民地形成,迁移 (伤口愈合),入侵和体内瘤发生 (异种移植模型).
- 使用定量RT-PCR分析了增殖标志物和Wnt/β-catenin介导的上皮层-介质细胞过渡 (EMT) 标志物.
主要成果:
- MFN2的淘汰显著降低了SiHa细胞的增殖,殖民地形成,迁移,入侵和体内瘤的生长.
- 抑制MFN2抑制了Wnt/β-catenin介导的EMT,降低了细胞移动性.
- 过度表达MFN2有助于宫癌的进展和瘤发生.
结论:
- 在促进宫癌的进展和瘤发生方面,MFN2起着至关重要的作用.
- 准MFN2可能为宫癌提供一种新的治疗策略.
- MFN2是宫癌的潜在预后生物标志物.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
相关概念视频
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Cancer Cell Migration through Invadopodia
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...